|
|
|
| home > white papers > Financial implications of off-site visits in clinical research, perception versus reality - Illingworth Research |
|
|
 WHITE PAPERS |
|
Illingworth Research
|
|
Financial implications of off-site visits in clinical research, perception versus reality
|
|
The concept of patient centricity is still relatively new within
clinical trials. For too long, the most important person in the trial
has been overlooked… the patient. Here, we explore the benefits of
conducting a more patient-centric trial for the patient, site and
sponsor through mobile, or ‘off -site’ visits. These advantages are much
greater than purely financial, although the financial implications of
running a more patient-focused clinical trial may previously have
deterred some from this approach. Home nursing in clinical trials
continues to be thought of as a high value “premium” service, which many
sponsors decline in an attempt to remain within budget for the trial.
However, is the actual cost of off -site nursing more expensive than the
traditional site model?
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation
SAN DIEGO, Calif. & CAMBRIDGE, England, May 20, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, and Mundipharma today announced that the first patient has been dosed in its ReSPECT pivotal Phase 3 clinical trial evaluating the efficacy and safety of the company’s lead antifungal candidate, rezafungin, for the prevention of invasive fungal disease in patients undergoing allogeneic blood and marrow transplantation (BMT). Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of severe fungal infections.
More info >> |
|
 |
White Papers |
 |
|
Role of Comparators in Clinical Trial Supply
Clinical Services International
CSI analyses the role of comparators in different trial designs and offers expert advice on robust methodology for choosing the most appropriate comparators. Case studies provide real insight on how to choose comparators for rare diseases and oncology studies.
More info >> |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
.jpg)
